Your browser doesn't support javascript.
loading
Identification of prognostic values defined by copy number variation, mRNA and protein expression of LANCL2 and EGFR in glioblastoma patients.
Zhao, Hua-Fu; Zhou, Xiu-Ming; Wang, Jing; Chen, Fan-Fan; Wu, Chang-Peng; Diao, Peng-Yu; Cai, Lin-Rong; Chen, Lei; Xu, Yan-Wen; Liu, Jing; Li, Zong-Yang; Liu, Wen-Lan; Chen, Zhong-Ping; Huang, Guo-Dong; Li, Wei-Ping.
Afiliação
  • Zhao HF; Department of Neurosurgery, Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, 518035, China.
  • Zhou XM; Department of Neurosurgery, Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, 518035, China.
  • Wang J; Epilepsy Center, Guangdong 999 Brain Hospital, Guangzhou, 510510, China.
  • Chen FF; Department of Neurosurgery/Neuro-Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
  • Wu CP; State Key Laboratory of Oncology in South China, Guangzhou, 510060, China.
  • Diao PY; Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
  • Cai LR; Department of Neurosurgery, Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, 518035, China.
  • Chen L; Department of Neurosurgery, Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, 518035, China.
  • Xu YW; Department of Neurosurgery, People's Hospital of Longhua District, Shenzhen, 518109, China.
  • Liu J; Department of Neurosurgery, Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, 518035, China.
  • Li ZY; Department of Neurosurgery, Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, 518035, China.
  • Liu WL; Department of Neurosurgery, Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, 518035, China.
  • Chen ZP; Department of Neurosurgery, Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, 518035, China.
  • Huang GD; Department of Pathology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, 518035, China.
  • Li WP; Department of Neurosurgery, Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, 518035, China.
J Transl Med ; 19(1): 372, 2021 08 30.
Article em En | MEDLINE | ID: mdl-34461927
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Proteínas de Ligação a Fosfato / Receptores ErbB / Proteínas de Membrana Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Proteínas de Ligação a Fosfato / Receptores ErbB / Proteínas de Membrana Idioma: En Ano de publicação: 2021 Tipo de documento: Article